The CBD Study
The study drug is a potential new treatment for autism spectrum disorder (ASD).
Cannabidiol (CBD) is a cannabinoid that occurs naturally in the Cannabis sativa L. plant, which has been previously demonstrated to have an anti-panic effect.
The study drug is a drug/device combination product that can potentially treat performance anxiety in SAD. After inhalation through the device, the drug dissolves rapidly in the lungs and is absorbed into the bloodstream. Once in the bloodstream, CBD has the same effect that would be observed using other ways of administration but may reach the blood faster when inhaled.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!